Kenneth J. Fasola - 02 Dec 2021 Form 4 Insider Report for MAGELLAN HEALTH INC

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth J. Fasola
Issuer symbol
N/A
Transactions as of
02 Dec 2021
Net transactions value
-$319,437
Form type
4
Filing time
06 Dec 2021, 16:13:38 UTC
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGLN Ordinary Common Stock, $0.01 par value Options Exercise $0 +8,580 +72% $0.000000 20,517 02 Dec 2021 Direct F1, F2
transaction MGLN Ordinary Common Stock, $0.01 par value Tax liability $319,437 -3,376 -16% $94.62 17,141 02 Dec 2021 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGLN Restricted Stock Units Options Exercise $0 +8,580 $0.000000 8,580 02 Dec 2021 Common Stock 8,580 $0.000000 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on December 2, 2019. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
F2 Not applicable.
F3 Represents the portion of shares withheld by the Company in order to pay taxes.
F4 Closing price on NASDAQ on December 2, 2021.
F5 The remainder of 8,580 Restricted Stock Units shall vest on December 2, 2022, subject to earlier acceleration or forfeiture.